Search

Displaying results 9401 - 9410 of 10000 in total
  1. Drug

    Regrelor

    go.drugbank.com/drugs/DB05553
    Investigational

  2. Drug

    XL999

    go.drugbank.com/drugs/DB05014
    Investigational

    XL999 induces a cell-cycle block by a mechanism distinct from those previously identified and exhibits broad antitumor activity in xenograft models. … XL999 is a new chemical entity that inhibits a spectrum of receptor tyrosine kinases (RTKs) with growth promoting and angiogenic properties, including FGFR 1/3, PDGFRα/β, VEGFR2/KDR, KIT, and FLT3.

  3. Drug

    PRX-08066

    go.drugbank.com/drugs/DB05607
    Investigational

  4. Drug

    Faropenem medoxomil

    go.drugbank.com/drugs/DB05659
    Investigational

    Faropenem medoxomil is a broad-spectrum antibiotic that is highly resistant to beta-lactamase degradation. It is being developed jointly by Replidyne, Inc. and Forest Laboratories, Inc.

  5. Drug

    ASF-1075

    go.drugbank.com/drugs/DB05727
    Experimental

  6. Drug

    BG-777

    go.drugbank.com/drugs/DB05839
    Experimental

    BG-777 is an immunomodulator with proven efficacy against viral and bacterial infections in preclinical studies.

  7. Drug

    EMD-1201081

    go.drugbank.com/drugs/DB06181
    Investigational

  8. Drug

    Repifermin

    go.drugbank.com/drugs/DB06434
    Experimental

  9. Drug

    Edifoligide

    go.drugbank.com/drugs/DB06556
    Investigational

  10. Drug

    Eliapixant

    go.drugbank.com/drugs/DB21465
    Investigational

    Eliapixant has a monoisotopic molecular weight of 478.13 Da. … Eliapixant is a small molecule drug. The usage of the INN stem '-pixant' in the name indicates that Eliapixant is a purinoreceptor (P2X) antagonist.